U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Urofacial syndrome type 1

MedGen UID:
1684629
Concept ID:
CN033872
Disease or Syndrome
Synonym: HPSE2-Related Urofacial Syndrome
 
Gene (location): HPSE2 (10q24.2)
 
Monarch Initiative: MONDO:0009368
OMIM®: 236730

Disease characteristics

Excerpted from the GeneReview: Urofacial Syndrome
Urofacial syndrome (UFS; also known as Ochoa syndrome) is characterized by prenatal or childhood onset of urinary bladder voiding dysfunction, abnormal facial movement with expression (resulting from abnormal co-contraction of the corners of the mouth and eyes), and often bowel dysfunction (constipation and/or encopresis). Bladder voiding dysfunction can present before birth as megacystis. In infancy and later childhood, UFS can present with a poor urinary stream and dribbling incontinence; incomplete bladder emptying can lead to urinary infection with progressive kidney failure. Investigations after birth can show abnormal bladder contractility and vesicoureteral reflux of urine into the ureter and renal pelvis. Nocturnal lagophthalmos (incomplete closing of the eyes during sleep) has also been documented. [from GeneReviews]
Authors:
William G Newman  |  Adrian S Woolf  |  Glenda M Beaman, et. al.   view full author information

Additional description

From OMIM
The urofacial syndrome (UFS) is a rare autosomal recessive disease characterized by a severe and early-onset form of dysfunctional urinary voiding. Affected individuals usually present prenatally or in early childhood with grossly distorted renal tracts, comprising dysmorphic bladders and dilatation of the ureter and renal pelvis. They are at high risk of vesicoureteral reflux (VUR), with ascending bacterial infection leading to kidney damage, hypertension, and renal failure. One-third of UFS children also experience constipation or fecal soiling, suggesting that the pathophysiology of the syndrome encompasses a broader functional impairment of elimination. In addition, affected individuals have a characteristic facial grimace when trying to smile (summary by Daly et al., 2010). Genetic Heterogeneity of Urofacial Syndrome Urofacial syndrome-2 (UFS2; 615112) is caused by mutation in the LRIG2 gene (608869) on chromosome 1p13.  http://www.omim.org/entry/236730

Recent clinical studies

Etiology

Stuart HM, Roberts NA, Hilton EN, McKenzie EA, Daly SB, Hadfield KD, Rahal JS, Gardiner NJ, Tanley SW, Lewis MA, Sites E, Angle B, Alves C, Lourenço T, Rodrigues M, Calado A, Amado M, Guerreiro N, Serras I, Beetz C, Varga RE, Silay MS, Darlow JM, Dobson MG, Barton DE, Hunziker M, Puri P, Feather SA, Goodship JA, Goodship TH, Lambert HJ, Cordell HJ; UK VUR Study Group, Saggar A, Kinali M; 4C Study Group, Lorenz C, Moeller K, Schaefer F, Bayazit AK, Weber S, Newman WG, Woolf AS
J Am Soc Nephrol 2015 Apr;26(4):797-804. Epub 2014 Aug 21 doi: 10.1681/ASN.2013090961. PMID: 25145936Free PMC Article

Diagnosis

Cesur Baltacı HN, Taşdelen E, Topçu V, Eminoğlu FT, Karabulut HG
J Pediatr Endocrinol Metab 2021 May 26;34(5):653-657. Epub 2021 Feb 26 doi: 10.1515/jpem-2020-0367. PMID: 33647194

Prognosis

Cesur Baltacı HN, Taşdelen E, Topçu V, Eminoğlu FT, Karabulut HG
J Pediatr Endocrinol Metab 2021 May 26;34(5):653-657. Epub 2021 Feb 26 doi: 10.1515/jpem-2020-0367. PMID: 33647194

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...